Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Cerus Corporation

CERSNASDAQ
Healthcare
Medical - Devices
$1.69
$-0.01(-0.59%)
U.S. Market opens in 13h 22m

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap324.8M
P/E Ratio-20.55
EPS (TTM)$-0.08
ROE-0.26%
Fundamental Analysis

AI Price Forecasts

1 Month$2.05
3 Months$2.69
1 Year Target$1.88

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.26, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.88.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -20.55 and a market capitalization of 324.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.59%
5-Day Change
-21.40%
1-Month Change
-24.55%
3-Month Change
-22.48%
6-Month Change
37.40%
Year-to-Date (YTD) Change
-14.21%
1-Year Change
21.58%
3-Year Change
-42.12%
5-Year Change
-73.68%
All-Time (Max) Change
-86.06%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

6,140 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions